Immune Tolerance
Immunological tolerance is the failure to mount an immune response to an antigen. It can be: Natural or "self" tolerance. This is the failure (a good thing) to attack the body's own proteins and other antigens. If the immune system should respond to "self", an autoimmune disease may result. Natural or "self" tolerance: Induced tolerance: This is tolerance to external antigens that has been created by deliberately manipulating the immune system.
Related Conference of Immune Tolerance
March 09-10, 2026
21th International Conference on Allergic Diseases and Clinical Immunology
Singapore City, Singapore
April 16-17, 2026
13th World Congress and Exhibition on Antibiotics and Antibiotic Resistance
London, UK
Immune Tolerance Conference Speakers
Recommended Sessions
- Antibodies: Engineering and Therapeutics
- Cancer and Tumor Immunobiology
- Immune Tolerance
- Viral Immunology: Emerging and Re-emerging Diseases
- Allergy and Asthma
- Antibiotics and Current Research
- Autoimmune Diseases
- Clinical Immunology: Current & Future Research
- Immuno Cytochemistry, Immunohistochemistry and Immunobiology
- Immunodeficiency
- Immunology and Diabetes
- Immunopathology
- Immunotherapy & Cancer Immunotherapy: From Basic Biology to Translational Research
- Immunotoxicology
- Infectious Diseases, Emerging and Reemerging diseases: Confronting Future Outbreaks
- Inflammation and Therapies
- Innate Immunity: An Emerging Science
- Molecular and Structural Immunology
- Neuroimmunology
- Pediatric Immunology
- Transplantation Immunology
- Vaccines and Immunotherapy
Related Journals
Are you interested in
- Antibiotic Prophylaxis - Antibiotics 2026 (UK)
- Antibiotic Resistance: Opportunities and Challenges - Antibiotics 2026 (UK)
- Antibiotic-resistant Bacterial infections - Antibiotics 2026 (UK)
- Antibiotics - Antibiotics 2026 (UK)
- Antibiotics for Various Diseases and Infections - Antibiotics 2026 (UK)
- Antibiotics: In Pregnancy and Lactation - Antibiotics 2026 (UK)
- Antimicrobial Peptides - Antibiotics 2026 (UK)
- Antimicrobial Therapy - Antibiotics 2026 (UK)
- Clinical Trials of Antibiotics - Antibiotics 2026 (UK)
- Current Research in Antibiotic Resistance - Antibiotics 2026 (UK)
- Developing Alternatives to Antibiotics - Antibiotics 2026 (UK)
- Drug Discovery and Novel Delivery Technologies - Antibiotics 2026 (UK)
- Immunology & Vaccines - Antibiotics 2026 (UK)
- Infectious Diseases - Antibiotics 2026 (UK)
- Mechanisms and Evolution of Antibiotic Resistance - Antibiotics 2026 (UK)
- Micro Organisms in Recent Drug Discovery - Antibiotics 2026 (UK)
- Microorganisms Producing Antibiotics - Antibiotics 2026 (UK)
- Modern Antibiotics for Various Diseases and Infections - Antibiotics 2026 (UK)
- New antibiotics and non-antibiotic approaches - Antibiotics 2026 (UK)
- Pharmacokinetics and Pharmacodynamics of Antimicrobial Drugs - Antibiotics 2026 (UK)
- Pharmacology & Toxicology - Antibiotics 2026 (UK)
- Prevention and Control of Antibiotic Resistance - Antibiotics 2026 (UK)
- The Next Generation Approach of Antibiotics - Antibiotics 2026 (UK)